ACTIVE

Centre de Coordination et de Référence pour le dépistage des cancers

Financial year 2025 · closed on 31/12/2025
Net result
140,4 k €
+99.9% YoY
Gross margin
747,3 k €
+13.0% YoY
Equity
518,3 k €
+37.1% YoY
Workforce
7,0 ETP
+1.4% YoY

What does Centre de Coordination et de Référence pour le dépistage des cancers do?

Centre de Coordination et de Référence pour le dépistage des cancers is a Non-profit organization incorporated in 2002. Its main activity is: Activities of other membership organisations n.e.c.. Its registered office is in Mont-Saint-Guibert. It employs on average 7,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0478.939.973
Incorporation
02/08/2002
Legal form
Non-profit organization
Registered office
Rue André Dumont 5
1435 Mont-Saint-Guibert · WallonieSee on map
Latest accounts
31/12/2025
Average workforce
7,0 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 18 financial years

202520242023202220212020201920182017201620152014201320122011201020092008
Income statement
Gross margin747,3 k €661,2 k €592,6 k €592,6 k €581,7 k €687,6 k €442,0 k €397,9 k €383,2 k €475,9 k €510,2 k €413,3 k €441,6 k €439,4 k €365,0 k €341,1 k €269,4 k €108,3 k €
EBITDA161,7 k €90,7 k €1,2 k €31,0 k €67,7 k €60,9 k €-100,6 k €17,3 k €36,5 k €80,3 k €124,7 k €20,9 k €23,4 k €33,8 k €17,1 k €23,6 k €6,7 k €40,7 k €
Operating result135,9 k €77,6 k €224,8 €28,9 k €61,6 k €51,9 k €-112,8 k €7,4 k €28,5 k €73,7 k €117,5 k €-2,8 k €-874,0 €3,2 k €-8,0 k €-2,7 k €-5,6 k €31,9 k €
Net result140,4 k €70,2 k €-5,3 k €25,0 k €57,5 k €48,9 k €-115,6 k €3,6 k €26,4 k €70,1 k €116,0 k €0,0 €0,0 €0,0 €0,0 €0,0 €0,0 €29,4 k €
Balance sheet
Equity518,3 k €378,1 k €308,1 k €313,6 k €288,9 k €230,8 k €181,5 k €297,1 k €294,7 k €270,3 k €205,6 k €94,1 k €103,6 k €124,8 k €133,2 k €110,6 k €52,2 k €58,7 k €
Total assets1,2 M €765,5 k €517,0 k €546,0 k €492,4 k €486,8 k €437,0 k €471,7 k €506,5 k €459,2 k €337,4 k €1,1 M €1,0 M €965,9 k €923,0 k €1,2 M €1,1 M €560,0 k €
Cash997,7 k €206,6 k €198,1 k €221,6 k €161,2 k €218,6 k €156,6 k €220,6 k €251,3 k €97,0 k €30,1 k €49,1 k €26,9 k €111,2 k €2,6 k €64,6 k €132,3 k €112,1 k €
Debts502,5 k €173,5 k €169,0 k €192,5 k €163,0 k €215,5 k €255,5 k €165,9 k €211,8 k €188,9 k €131,8 k €92,0 k €125,2 k €134,0 k €107,9 k €180,5 k €178,2 k €102,3 k €
Other
Workforce7,0 ETP6,9 ETP7,4 ETP7,3 ETP7,0 ETP8,0 ETP8,5 ETP6,9 ETP7,3 ETP6,9 ETP7,0 ETP7,6 ETP8,8 ETP7,4 ETP8,0 ETP7,3 ETP6,6 ETP1,8 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 12 active · 45 ended

Active mandates

Laurence COTE

Director · since 27 juin 2023

Active
André-Robert Grivegnée

Vice-chairman of the board of directors · since 29 mai 2018

Active
Bruno VANDERMEERSCH

Director · since 29 mai 2018

Active
Jean-Benoit BURRION

Director · since 29 mai 2018

Active
Julie Francart

Director · since 29 mai 2018

Active
Martine Berlière

Director · since 29 mai 2018

Active
Yves GUEUNING

Director · since 29 mai 2018

Active
Daniel Faverly

Director

Active
Hélène De Pauw

Director

Active
Marc VAN DEN EYNDE

Chairman of the board of directors

Active
Michèle GUILLAUME

Director

Active
Valérie CELIS

Director

Active

Ended mandates

Pierre-François DEFER

Director · since 25 juin 2019 · until 01 juin 2022

Ended
Maria GOESSENS

Director · since 29 mai 2019 · until 01 juin 2022

Ended
Martine Berlière

Director · since 29 mai 2019 · until 01 juin 2022

Ended
André-Robert Grivegnée

Vice-chairman of the board of directors · since 29 mai 2018 · until 01 juin 2022

Ended
At this address

Other companies at this address

CompanyCBE no.
3D-SIDEActive
0597.918.094
EsoBiotecActive
0756.885.159
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date07/07/202616/07/202503/07/202413/07/202327/06/202222/07/2021
General meeting22/06/202617/06/202517/06/202427/06/202321/06/202229/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

18 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202522/06/202607/07/2026FrenchPDF
Abridged model31/12/202417/06/202516/07/2025FrenchPDF
Abridged model31/12/202317/06/202403/07/2024FrenchPDF
Abridged model31/12/202227/06/202313/07/2023FrenchPDF
Abridged model31/12/202121/06/202227/06/2022FrenchPDF
Abridged model31/12/202029/06/202122/07/2021FrenchPDF
Abridged model31/12/201903/09/202029/09/2020FrenchPDF
Abridged model31/12/201825/06/201910/07/2019FrenchPDF
Abridged model31/12/201729/05/201810/07/2019FrenchPDF
Abridged model31/12/201601/06/201730/06/2017FrenchPDF
Abridged model31/12/201509/06/201604/07/2016FrenchPDF
Abridged model31/12/201428/05/201506/07/2015FrenchPDF
Abridged model31/12/201319/06/201413/08/2014FrenchPDF
Abridged model31/12/201228/05/201327/06/2013FrenchPDF
Abridged model31/12/201116/07/201221/08/2012FrenchPDF
Abridged model31/12/201009/06/201129/06/2011FrenchPDF
Abridged model31/12/200924/06/201015/07/2010FrenchPDF
Abridged model31/12/200825/06/200930/07/2009FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 12 active · 45 ended

Active mandates

Laurence COTE

Director · since 27 juin 2023

Active
André-Robert Grivegnée

Vice-chairman of the board of directors · since 29 mai 2018

Active
Bruno VANDERMEERSCH

Director · since 29 mai 2018

Active
Jean-Benoit BURRION

Director · since 29 mai 2018

Active
Julie Francart

Director · since 29 mai 2018

Active
Martine Berlière

Director · since 29 mai 2018

Active
Yves GUEUNING

Director · since 29 mai 2018

Active
Daniel Faverly

Director

Active
Hélène De Pauw

Director

Active
Marc VAN DEN EYNDE

Chairman of the board of directors

Active
Michèle GUILLAUME

Director

Active
Valérie CELIS

Director

Active

Ended mandates

Pierre-François DEFER

Director · since 25 juin 2019 · until 01 juin 2022

Ended
Maria GOESSENS

Director · since 29 mai 2019 · until 01 juin 2022

Ended
Martine Berlière

Director · since 29 mai 2019 · until 01 juin 2022

Ended
André-Robert Grivegnée

Vice-chairman of the board of directors · since 29 mai 2018 · until 01 juin 2022

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other15/07/2026
    PDF
  • Mandates15/07/2024
    DENOMINATION
    PDF
  • Other11/01/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates14/08/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/01/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/10/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/07/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/07/2018
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025140,4 k €
  2. 2024
    Annual accounts 202470,2 k €
  3. 2024
    Name changeCentre de Coordination et de Référence pour le dépistage des cancers
  4. 2023
    Annual accounts 2023-5,3 k €
  5. 2022
    Annual accounts 202225,0 k €
  6. 2021
    Annual accounts 202157,5 k €
  7. 2020
    Annual accounts 202048,9 k €
  8. 2019
    Annual accounts 2019-115,6 k €
  9. 2018
    Annual accounts 20183,6 k €
  10. 2017
    Annual accounts 201726,4 k €
  11. 2016
    Annual accounts 201670,1 k €
  12. 2015
    Annual accounts 2015116,0 k €
  13. 2014
    Annual accounts 20140,0 €
  14. 2013
    Annual accounts 20130,0 €
  15. 2012
    Annual accounts 20120,0 €
  16. 2011
    Annual accounts 20110,0 €
  17. 2010
    Annual accounts 20100,0 €
  18. 2009
    Annual accounts 20090,0 €
  19. 2008
    Annual accounts 200829,4 k €
  20. 2008
    Name changeCentre Communautaire de Référence pour le dépistage des cancers
  21. 02/08/2002
    IncorporationNon-profit organization